201 related articles for article (PubMed ID: 29237362)
1. De Novo Malignancies After Liver Transplantation: A Single Institution Experience.
Egeli T; Unek T; Ozbilgin M; Agalar C; Derici S; Akarsu M; Unek IT; Aysin M; Bacakoglu A; Astarcıoglu I
Exp Clin Transplant; 2019 Feb; 17(1):74-78. PubMed ID: 29237362
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant malignancies in liver transplant recipients.
Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
[TBL] [Abstract][Full Text] [Related]
3. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center.
Liu ZN; Wang WT; Yan LN;
Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956
[TBL] [Abstract][Full Text] [Related]
4. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
[TBL] [Abstract][Full Text] [Related]
5. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
6. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
7.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
8. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
9. De novo tumors after liver transplantation: a single-institution experience.
Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
[TBL] [Abstract][Full Text] [Related]
10. De novo malignancy after lung transplantation in Japan.
Miyazaki T; Oto T; Okumura M; Date H; Shiraishi T; Okada Y; Chida M; Kondo T; Nagayasu T
Gen Thorac Cardiovasc Surg; 2016 Sep; 64(9):543-8. PubMed ID: 27270709
[TBL] [Abstract][Full Text] [Related]
11. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
[TBL] [Abstract][Full Text] [Related]
12. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract][Full Text] [Related]
13. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
[TBL] [Abstract][Full Text] [Related]
14. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
15. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
Jain AB; Yee LD; Nalesnik MA; Youk A; Marsh G; Reyes J; Zak M; Rakela J; Irish W; Fung JJ
Transplantation; 1998 Nov; 66(9):1193-200. PubMed ID: 9825817
[TBL] [Abstract][Full Text] [Related]
16. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
17. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
Yao FY; Gautam M; Palese C; Rebres R; Terrault N; Roberts JP; Peters MG
Clin Transplant; 2006; 20(5):617-23. PubMed ID: 16968488
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of de novo malignancies in liver transplantation].
Catalina MV; de Diego A; García-Sánchez A; Escudero M; Salcedo M; Bañares R; Clemente G
Gastroenterol Hepatol; 2003 Feb; 26(2):57-63. PubMed ID: 12570889
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
20. Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation.
Aguiar D; Martínez-Urbistondo D; D'Avola D; Iñarrairaegui M; Pardo F; Rotellar F; Sangro B; Quiroga J; Herrero JI
Ann Transplant; 2017 Mar; 22():141-147. PubMed ID: 28302995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
